Mitochondrial inner membrane lipid bilayer (IMM)

The mitochondrial inner membrane lipid bilayer is a highly specialized structure that serves as the primary site for cellular energy production via oxidative phosphorylation. It is characterized by a high protein-to-lipid ratio and the presence of the unique phospholipid cardiolipin, which is crucial for the stability of the electron transport chain complexes and the formation of respiratory supercomplexes (Paradies et al., 2014, PubMed). This membrane maintains the electrochemical gradient necessary for ATP synthesis and plays a vital role in regulating programmed cell death through the sequestration and release of cytochrome c (StatPearls, 2023). Pathological alterations in the lipid composition, particularly the oxidation or depletion of cardiolipin, are associated with a wide range of conditions including heart failure, neurodegeneration, and ischemia-reperfusion injury (Chavez et al., 2020, PubMed). Pharmacological targeting of this bilayer focuses on stabilizing its lipid components to restore mitochondrial morphology and bioenergetic capacity. Drugs such as elamipretide (SS-31) interact directly with cardiolipin to prevent its conversion into a pro-oxidant, thereby protecting the membrane from oxidative damage and improving metabolic function in energy-intensive tissues (Birk et al., 2013, PubMed). By maintaining the integrity of the inner membrane, these therapies aim to mitigate cellular damage and enhance overall mitochondrial health.

Other names

Inner mitochondrial membraneMitochondrial inner membraneMIMCristae membrane

Drugs targeting this bilayer, such as elamipretide, bind selectively to cardiolipin, a unique phospholipid found within the inner membrane. This binding stabilizes the cardiolipin-cytochrome c complex, preventing cardiolipin from acting as a peroxidase and maintaining the structural integrity of the mitochondrial cristae. By preserving the membrane architecture, these agents optimize the efficiency of the electron transport chain and reduce the production of reactive oxygen species (ROS).